The $161.1M raise provides a substantial cash runway for Immatics' pipeline development, but the ~20%+ dilution (relative to pre-offering share count) creates near-term overhang. Monitor for any pipeline catalysts or partnership announcements that could offset dilution concerns; the stock may trade lower as the market absorbs the new shares.
IMTX drugs
IMTX drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 27 $9.36entry
- T+1 · 3mo ago +0.96%α +1.19% · $9.45
- T+5 · 3mo ago +1.07%α +0.80% · $9.46
- T+20 · 8w ago −11.00%α −10.50% · $8.33
- T+56 · todayOpen
- T+60 · in 3d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Immatics N.V. completed a public offering of 15,535,100 ordinary shares and pre-funded warrants to purchase 4,315,304 ordinary shares, raising approximately $161.1 million in net proceeds. The offering is dilutive to existing shareholders but provides significant cash runway to fund R&D and potential commercialization of its pipeline. The filing is bearish due to the certain present dilution from the share issuance, which outweighs the future-avoided benefit of the pre-funded warrant structure.
Key Facts
- Immatics completed an offering of 15,535,100 ordinary shares and pre-funded warrants to purchase 4,315,304 ordinary shares.
- Net proceeds from the offering are approximately $161.1 million.
- The offering price per share was $8.69, and per pre-funded warrant was $8.689.
- Underwriters' option to purchase 2,589,814 additional ordinary shares was exercised in full.
- Proceeds will fund R&D, manufacturing, potential commercialization, and working capital.
Financial Impact
Approximately $161.1 million in net proceeds raised through issuance of 15,535,100 ordinary shares and pre-funded warrants for 4,315,304 shares, representing significant dilution to existing shareholders.
Risk Factors
- Significant dilution to existing shareholders from the issuance of 15.5M new shares and potential exercise of pre-funded warrants.
- Proceeds are for R&D and commercialization, which carry execution risk and no guarantee of near-term revenue.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (IMTX), Batch item 1 | 0001193125-26-368946 |
| Document: 0001193125-26-368946-index-headers.html | 0001193125-26-368946 |
| Document: 0001193125-26-368946-index.html | 0001193125-26-368946 |
| Document: 0001193125-26-368946.txt | 0001193125-26-368946 |
| 6-K Filing (IMTX), Batch item 5 | 0001193125-26-368946 |
Track record
23 reports on IMTX
8 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +22.12% at T+20 after the May 12, 2026 report. 8 of 13 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $6.24 Now $6.17 −1.12% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $6.55 Now $6.17 −5.73% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 5/10 No price data
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $6.42 Now $6.17 −3.89% settles Nov 17
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
- Oct 24, 202624d ago Press Release Bullish 6/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
- Oct 23, 202624d ago 6-K Bullish 7/10 Entry $7.31 to $7.20 Now $6.17 −15.60% ▼ −1.50% −0.95% vs SPY
- Aug 27, 202611w ago Insider Buy Bullish 6/10 Entry $9.45 to $9.56 Now $6.17 −34.71% ▲ +1.16% +1.05% vs SPY
- Aug 26, 202611w ago 6-K Bearish 6/10 Viewing Entry $9.36 to $9.46 Now $6.17 +34.08% ▼ −1.07% −0.80% vs SPY
- Aug 18, 202612w ago 6-K Neutral 6/10 Entry $9.09 to $9.24 Now $6.17 −32.12% ▲ +1.65% +1.85% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers